Previous 10 | Next 10 |
Image source: The Motley Fool. Medpace Holdings, Inc. Common Stock (NASDAQ: MEDP) Q4 2021 Earnings Call Feb 15, 2022 , 9:00 a.m. ET Operator Continue reading For further details see: Medpace Holdings, Inc. Common Stock (MEDP) Q4 2021 Earn...
Although Medpace Holdings' (NASDAQ:MEDP) Q4 2021 results beat on the bottom line, its stock price took a licking today as some investors may have been disappointed by its fiscal year 2022 outlook. Medpace (MEDP) is backing a fiscal year 2022 outlook of revenue of $1.4B-$1.46B. Consensus is $1...
Medpace Holdings, Inc. (MEDP) Q4 2021 Earnings Conference Call February 15, 2022, 09:00 ET Company Participants Lauren Morris - Associate Director, Investors Relations August Troendle - Chairman & CEO Jesse Geiger - President Kevin Brady - CFO & Treasurer Conference Call Participants ...
Gainers: Brookdale Senior Living BKD +16%. American Shared Hospital Services AMS +12%. ImmunityBio IBRX +12%. I-Mab (NASDAQ:IMAB) +11%. Corvus Pharmaceuticals (NASDAQ:CRVS) +9%. Losers: Larimar Therapeutics LRMR -65%. Omnicell (NASDAQ:OMCL) -18%. M...
The following slide deck was published by Medpace Holdings, Inc. in conjunction with their 2021 Q4 earnings call. For further details see: Medpace Holdings, Inc. 2021 Q4 - Results - Earnings Call Presentation
Medpace press release (NASDAQ:MEDP): Q4 GAAP EPS of $1.32 beats by $0.07. Revenue of $308.55M (+18.8% Y/Y) misses by $0.48M. For further details see: Medpace GAAP EPS of $1.32 beats by $0.07, revenue of $308.55M misses by $0.48M
Revenue of $308.6 million in the fourth quarter of 2021 increased 18.8% from revenue of $259.7 million for the comparable prior-year period, representing a backlog conversion rate of 16.7%; Full year 2021 revenue of $1,142.4 million increased 23.4% from full year 2020. Net n...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its fourth quarter and fiscal year 2021 financial results after the market close on Monday, February 14, 2022. The Company will host a conference call the following morning, Tuesday, Febr...
James Star, the Executive Chairman of Canadian investment firm Longview Asset Management, purchased $1.79 million worth of Chewy shares. Chewy went on a roller coaster ride from its $22 IPO price in June 2019 to a high of nearly $120 by February 2021. The pandemic related tailwind...
Medpace supports the biopharmaceutical industry with state of the art research methods to accelerate the approval of drugs. The CRO market is highly competitive, but the CEO specializes in a niche that allows almost predictable sales for the upcoming years. The company is profitab...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...